Capital Offload-Shock
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 456 participants.
Also called NCT07756801
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 456 participants
- Registry
-
NCT07756801
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07756801. Randomized; no masking; primary purpose treatment. Start 2026-12-01 (anticipated); primary completion 2027-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Capital Offload-Shock
- Acronym
- OFFLOAD-SHOCK
- Condition
- Hypervolemia
- Condition
- Cardiogenic Shock
- Condition
- Renal Replacement Therapies
- Intervention (Drug)
- Immediate renal replacement therapy
- Lead sponsor
- Ottawa Heart Institute Research Corporation
Record details
- Record id
cardio:ct-nct07756801- Content hash
ff85e4dcbf7f2dc8dd837e387be96fe1f3e77c69dfdeb8f050ede663cb15e3d1